|
|
| | 259794-08-6 Basic information |
| Product Name: | 259794-08-6 | | Synonyms: | 6-Amino-3-methoxy Favipiravir;2-Pyrazinecarboxamide, 6-amino-3-methoxy- | | CAS: | 259794-08-6 | | MF: | C6H8N4O2 | | MW: | 168.15 | | EINECS: | | | Product Categories: | | | Mol File: | 259794-08-6.mol |  |
| | 259794-08-6 Chemical Properties |
| Melting point | 200°C | | Boiling point | 357.8±42.0 °C(Predicted) | | density | 1.391±0.06 g/cm3(Predicted) | | storage temp. | -20°C, Inert atmosphere | | solubility | DMSO (Slightly), Methanol (Slightly) | | form | Solid | | pka | 13.76±0.50(Predicted) | | color | Yellow to Dark Yellow |
| | 259794-08-6 Usage And Synthesis |
| Uses | 6-Amino-3-methoxy Favipiravir is an impurity of Favipiravir (F103350), which is used for the treatment of advanced Ebola virus infection in a small animal model. Favipiravir suppressed the replication of Zaire Ebola virus and prevented a lethal outcome in 100% of the animals. Based on the studies, Favipiravir can be a candidate for the treatment of Ebola hemorrhagic fever. It is a COVID19-related research product. |
| | 259794-08-6 Preparation Products And Raw materials |
|